Roche diagnostics corp:1106277 [16-004338]

Ended Awarded Last action

Contract number
HHSN26100007
Awardee
Awarding agency
Obligated
$37,811

Award facts

Opportunity
Contract value 100% obligated
$37,811.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Roche diagnostics corp:1106277 [16-004338] (BD biosciences) -$2,011
Original award $39,823

About this award

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on October 21, 2015, with a ceiling value of $37,811.40 for in vitro diagnostic products and services.

Place of performance is Bethesda, MD. The order was firm fixed price with an ultimate completion date of December 9, 2019. No set-aside was used.

Quick answers

Who was awarded contract HHSN26100007?

HHSN26100007 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on October 21, 2015.

How much is contract HHSN26100007 worth?

The government has obligated $37,811 on HHSN26100007.

Is contract HHSN26100007 an order under another contract?

Yes. HHSN26100007 is a delivery order under HHSN261201500001I, an indefinite delivery contract.

Was contract HHSN26100007 competed?

The extent of competition for HHSN26100007 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award